Triflusal

SIGMA/T6580 - ≥98% (HPLC), powder

Synonym: Triflusal; α,α,α-trifluoro-2,4-cresotic acid acetate; 2-(Acetyloxy)-4-(trifluoromethyl)benzoic acid; Drisgen; acetyl-4-trifluoromethylsalicylic acid

CAS Number: 322-79-2
Empirical Formula (Hill Notation): C₁₀H₇F₃O₄
Molecular Weight: 248.16
EC Number: 206-297-5
Linear Formula: C₁₀H₇F₃O₄
Product Type: Chemical

Catalog Number	PKG Qty.	Price


45-T6580-5MG	5 mg	$129.00 1/EA	Add To Favorites
45-T6580-25MG	25 mg	$0.00 1/EA CALL FOR PRICE	Add To Favorites

Properties
Descriptions
Safety Info.
Basic Data

assay	≥98% (HPLC)
color	white to off-white
form	powder
InChI	1S/C10H7F3O4/c1-5(14)17-8-4-6(10(11,12)13)2-3-7(8)9(15)16/h2-4H,1H3,(H,15,16)
InChI key	RMWVZGDJPAKBDE-UHFFFAOYSA-N
originator	Uriach
Quality Level	100
solubility	DMSO: >30 mg/mL
storage temp.	2-8°C

Biochem/physiol Actions:	Triflusal is an anti-inflammatory antithrombotic platelet aggregation inhibitor with a 3-fold mechanism of action. It is an irreversible inhibitor of COX-1 inhibiting thromboxane A2, preventing aggregation; it preserves vascular prostacyclin, thus promoting anti-aggregant effect. Triflusal blocks phosphodiesterase leading to an increase in cAMP levels promoting anti-aggregant effect due to inhibition of calcium mobilization.
Features and Benefits:	This compound was developed by Uriach . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here .
Packaging:	5, 25 mg in glass bottle

Symbol	GHS07
Signal word	Warning
Hazard statements	H302 - H315 - H317 - H319 - H335
Precautionary statements	P280 - P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338
Hazard Codes	Xn
Risk Statements	22-36/37/38-43
Safety Statements	26-36/37
RIDADR	NONH for all modes of transport
WGK Germany	WGK 3
Flash Point(F)	Not applicable
Flash Point(C)	Not applicable

Purity	≥98% (HPLC)
Storage Temp.	2-8°C
UNSPSC	12352200

To Order From a Quote